The US Food and Drug Administration (FDA) admonished Sun Pharmaceutical Industries in a recent warning ... These violations prompted FDA to place the firm on import alert on 7 December. FDA inspected ...

In a warning letter, the FDA has highlighted a series of lapses at Sun Pharma’s Gujarat plant, which has been put on an import alert list by the US drug regulator. In the letter dated December ...

For the US import alert to be lifted, Sun Pharma must conduct an independent, retrospective assessment of its cleaning effectiveness and cross-contamination hazards. The company was given 15 working ...

the FDA has highlighted a series of lapses at Sun Pharma’s Gujarat plant, which has been put on an import alert list by the US drug regulator.#sunpharma #halolfacility #usfda #cnbctv18 # ...

The company intends to increase its specialty drug portfolio in its core areas of dermatology and ophthalmology. This comes ...

The Food and Drug Administration is continuing its use of import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and modifies the alerts as needed.

India's largest drugmaker Sun Pharmaceuticals Ltd. is likely to report a healthy quarter despite the weakness from its ...

Sun Pharmaceutical, one of the world’s largest generic drugmakers, was scolded by the U.S. Food and Drug Administration for a host of serious manufacturing violations at a key plant in India ...

iBeat Analytics Ibeat 1 Year HTTPS To track article's statistics The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate ...

According to an ETNow poll, the drugmakers consolidated revenue for the quarter ended December is seen rising 12.5% on-year to Rs 11,100 crore ...

The Food and Drug Administration has filed a lawsuit accusing a Boca Raton pharmaceutical company of selling ... The company also imported ingredients from suppliers on the FDA’s Import Alerts list, ...

The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate written procedures designed to prevent microbiological contamination ...